BPC 157 500mcg (60 Capsules)

$348.00

PRODUCT SHORT DESCRIPTION

BPC-157 500mcg capsules deliver a high-purity synthetic stable gastric pentadecapeptide analogue configured for oral pharmacokinetic, gastrointestinal homeostasis, and systemic cytoprotection research. This 60-capsule configuration provides an exceptionally precise biochemical delivery system for investigating localized mucosal barrier repair, enteric nervous system interactions, and oral bioavailability kinetics.

Description

Introduction to Oral BPC-157 500mcg Capsules

BPC-157, biochemically classified as a synthetic pentadecapeptide ($\text{Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val}$), is a highly stable molecular probe engineered for intensive studies within gastroenterology, mucosal immunology, and systemic tissue architecture. Derived as a specific 15-amino-acid fragment from the endogenous body protection compound (BPC) isolated from mammalian gastric juice, BPC-157 plays a critical role in tracking epithelial barrier defense, microvascular proliferation cascades, and cell-autonomous repair profiles.

While traditional peptide research frequently relies on injectable formats to bypass enzymatic breakdown, BPC-157 possesses inherent conformational stability. This structural configuration allows it to withstand exposure to fluctuating pH levels and proteolytic enzymes within the digestive tract without undergoing immediate denaturing or inactivation. At USA PEPTIDE SCIENCES, we provide this foundational regenerative sequence in a precise oral capsule configuration (500mcg per capsule, 60 capsules per bottle), offering molecular biology and physiology laboratories a standardized vehicle to examine oral pharmacokinetics, localized enteric interactions, and systemic absorption curves under controlled laboratory conditions.

Research Overview: Oral Bioavailability and Enteric Cytoprotection

The primary scientific value of encapsulated BPC-157 500mcg centers on its capability to interface directly with the complex mucosal and vascular networks of the gastrointestinal tract before distributing systemically. By utilizing an oral delivery mechanism, researchers can map localized epithelial restoration against wider systemic repair loops.

Key areas of active scientific investigation utilizing oral BPC-157 500mcg include:

  • Gastrointestinal Mucosal Barrier Restoration: Modeling the repair kinetics of compromised epithelial linings. In animal models of inflammatory bowel disease (IBD), gastric ulcers, and intestinal hyperpermeability (“leaky gut”), oral BPC-157 is heavily studied for its capacity to stimulate tight junction proteins (such as zonula occludens-1) and accelerate the structural closure of mucosal lesions.

  • Localized and Systemic Angiogenesis: Investigating the upregulation of vascular endothelial growth factor (VEGF) signaling. Researchers analyze how oral administration influences the formation of new capillary branches within damaged gastrointestinal walls, as well as its downstream paracrine effects on distant musculoskeletal structures like tendons, ligaments, and skeletal muscle.

  • Nitric Oxide (NO) and Endothelial Homeostasis: Tracking the regulation of vascular endothelium and epithelial protection loops. BPC-157 exhibits a stabilizing interaction with both endothelial nitric oxide synthase ($\text{eNOS}$) and inducible nitric oxide synthase ($\text{iNOS}$). Researchers observe this feedback loop to evaluate how the compound normalizes vascular tone and limits chronic oxidative tissue stress.

  • Enteric Nervous System and Neuro-Endocrine Modulation: Exploring how the compound interacts with the gut-brain axis, local neurotransmitter pathways, and hormone regulation within the gastrointestinal nervous matrix to maintain systemic homeostatic baselines.

Pharmacokinetic Observations & Variable Tracking

When structuring laboratory protocols for encapsulated BPC-157, researchers typically evaluate a multi-capsule baseline deployment (such as two 500mcg capsules per serving) introduced alongside specific nutritional matrices to track absorption variables. In animal and laboratory models, key physiological baselines under active monitoring include:

  • Insulin Sensitivity and Glycemic Kinetics: Tracking fluctuations in insulin receptor sensitivity and glucose clearance curves to evaluate metabolic neutrality.

  • Fluid Dynamics and Water Retention: Assessing alterations in extracellular fluid volume and electrolyte balance.

  • Systemic vs. Localized Resolution: Comparing oral delivery outcomes against traditional parenteral administration routes to map total systemic bioavailability and tissue-specific accumulation.

Quality Standards & Analytical Testing

At USA PEPTIDE SCIENCES, laboratory data integrity and compound reproducibility are the fundamental core of our manufacturing operations. Every single production lot of BPC-157 500mcg Capsules undergoes a strict quality control validation protocol to eliminate compounding variables and experimental artifacts. We utilize High-Performance Liquid Chromatography (HPLC) coupled with Mass Spectrometry (MS) to confirm an absolute chemical purity profile of 99% or greater for the active pentadecapeptide matrix before encapsulation. This rigorous analytical validation verifies the exact 15-amino-acid sequence composition, precise molecular weight, and correct spatial conformation while ensuring the total absence of residual synthesis reagents, heavy metals, or raw contaminants. A batch-specific Certificate of Analysis (COA) accompanies every order to guarantee absolute reproducibility.

Storage and Handling Requirements

To safeguard the delicate peptide bonds and prevent premature structural degradation of the encapsulated matrix, bottles must be stored long-term in a cool, dry environment, completely shielded from direct light, excessive heat, and ambient moisture. Keep the container tightly sealed with its moisture-absorbing desiccant intact when not in use. Prior to introducing the capsules into an experimental model, ensure the handling environment is climate-controlled to avoid humidity compromises to the capsule shell.

Research Use Disclaimer

The compounds distributed by USA PEPTIDE SCIENCES, including BPC-157 500mcg research capsules, are designated strictly for laboratory research purposes only. Under no circumstances are these products approved or intended for human or veterinary consumption, direct clinical diagnostics, or therapeutic drug administration. All handling, measuring, and experimental evaluation must be conducted exclusively by qualified scientific professionals within a certified and monitored research facility.

Reviews (0)
0 reviews
0
0
0
0
0

There are no reviews yet.

Be the first to review “BPC 157 500mcg (60 Capsules)”

Your email address will not be published. Required fields are marked *